CAS No 320-67-2 |
5-Azacytidinenull |
Inquiry |
CAS No 2353-33-5 |
5-Aza-2'-deoxycytidinenull |
Inquiry |
CAS No 289499-45-2 |
2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-,hydrochloride (1:2)null |
Inquiry |
CAS No 22432-93-5 |
1,3,5-Triazin-2(1H)-one,4-amino-1-(3,5-di-O-acetyl-2-deoxy-D-erythro-pentofuranosyl)-null |
Inquiry |
CAS No 210353-53-0 |
Gemifioxacin mesylatenull |
Inquiry |
CAS No 205393-22-2 |
2-Pyrazinecarboxamide,N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-null |
Inquiry |
CAS No 205393-21-1 |
Benzenepropanamide, a-amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-,hydrochloride (1:1), (aS)-null |
Inquiry |
CAS No 202467-69-4 |
3-[[[(2S,4S)-4-MERCAPTO-2-PYRROLIDINYL-1-(4-NITROBENZYLOXY)CARBONYL]CARBONYL]AMINO]BENZOIC ACIDnull |
Inquiry |
CAS No 191732-72-6 |
Lenalidomidenull |
Inquiry |
CAS No 196078-30-5 |
Pramlintide Acetatenull |
Inquiry |
CAS No 191217-81-9 |
Pramipexole dihydrochloride monohydratenull |
Inquiry |
CAS No 18883-66-4 |
Streptozocinnull |
Inquiry |
CAS No 179324-87-9 |
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetatenull |
Inquiry |
CAS No 16320-04-0 |
18,19-Dinorpregna-4,9,11-trien-20-yn-3-one,13-ethyl-17-hydroxy-, (17a)-null |
Inquiry |
CAS No 179324-69-7 |
Bortezomibnull |
Inquiry |
CAS No 161735-79-1 |
Rasagiline mesylatenull |
Inquiry |
CAS No 155213-67-5 |
Ritonavirnull |
Inquiry |
CAS No 155206-00-1 |
Bimatoprostnull |
Inquiry |
CAS No 153832-46-3 |
ERTAPENEMnull |
Inquiry |
CAS No 154361-50-9 |
Capecitabinenull |
Inquiry |
CAS No 153773-82-1 |
Ertapenem Sodiumnull |
Inquiry |
CAS No 150812-12-7 |
RETIGABINEnull |
Inquiry |
CAS No 1508-65-2 |
oxybutynin chloridenull |
Inquiry |
CAS No 149647-78-9 |
Vorinostatnull |
Inquiry |
CAS No 148408-66-6 |
docetaxel trihydratenull |
Inquiry |